Deeply undervalued · +41.8% margin of safety
Market outside MC distributionMarket €117.80 vs DCF €202.54 (post-governance). Even at the 5th-percentile Monte Carlo outcome (€163.24), intrinsic value exceeds today's price by 38%.
What it sells, where it sells
Operating segments — FY25 revenue €5.66B
Filling & Packaging is the volume; Lifecycle Service is the margin lever (recurring spares + Ingeniq subscriptions earn ~15-18% EBIT vs ~5-6% on new machines). Modeled as one consolidated segment.
Country mix (revenue-weighted)
~38% of revenue sits in emerging markets (MEA, LatAm, EM-APAC, Eastern Europe) — meaningfully higher EM exposure than European consumer peers, and the reason the cost-of-capital build carries a 1.8% country-risk premium.
Background — five things to know before the case
Context the share price doesn't carry on its face. Skim this once and the claims below read as evidence, not inside baseball.
- Family-controlled, but in the good way. The Kronseder family pool holds 51.9% via a formal "preserve the family character" agreement; the Schadeberg family (Krombacher brewery, historical customer) adds 5.8%. Three generations of CEOs, 75 years of pro-minority alignment: flat share count 2009-2025, 25-30% dividend payout, fortress balance sheet, disciplined bolt-on M&A from internal cash. The family vehicle (Schawei GmbH) was a net buyer at €140 in 2025. This drives the smallest governance haircut in the European watchlist — 5%, not the 15-25% a controlling block normally earns.
- Fortress balance sheet. €548M net cash, zero financial debt, equity ratio 42%, €888M undrawn credit lines, interest coverage 52×. The synthetic credit rating resolves to Aaa/AAA — the top of the table. A cyclical machinery slowdown cannot bend this company structurally; it can absorb several years of weak orders before any capital-allocation choice gets forced.
- Backlog €4.3B = ~9 months of locked-in revenue. Q1 2026 order intake +5.3% to €1.51B, book-to-bill 1.10, FY26 guidance reaffirmed (3-5% revenue, EBITDA 10.7-11.1%, ROCE 19-20%). The demand signal is not breaking — what looks like cycle-peak fear in the share price is anchored to one quarter of soft EPS, not to the order book.
- The Ingeniq subscription transition is a real 100bp drag through 2027. Management itself flags it. Krones is shifting spare-parts revenue from transactional to monthly uptime subscriptions — short-term margin headwind, long-term recurring annuity. The bear narrative treats this as evidence of commoditization; the order book and ROCE expansion (10% → 19% in five years) say it's a deliberate mix-shift.
- Revenue is ~91% export, with ~38% in emerging markets. US 18%, France 13%, Germany 9%, China 8%, Vietnam 7%, plus a meaningful Mexico / MEA / LatAm tail. That EM concentration is a real risk feature, not a data artifact — it shows up as a 1.8% country-risk premium in the cost of capital. Q1 2026 reported revenue −2.2% was almost entirely EM FX translation (cc was +1.4%).
Where we diverge from the sector
Each row asks: if we'd used the sector median for this one assumption instead of our override, how much would the per-share value change? Negative = our override is more conservative (worth less); positive = more aggressive (worth more). Skim down the rightmost column to see which bets are doing the work.
The story & the five claims
The 10-year story this DCF is built on, plus the five anchor claims that translate the story into DCF inputs.
The 10-year story
Krones is a 75-year-old German Mittelstand world-leader in beverage filling and packaging machinery — turnkey PET, glass, and can lines for global brewers and bottlers, with ~91% of revenue exported. The base case is not a re-rating story. It's a mature specialty-machinery franchise grinding revenue forward at ~4% Y1 declining to 2.4% terminal, while EBIT margin walks from 7.36% today to 8% by Y10 as the Lifecycle Service + Ingeniq subscription mix grows from ~30% toward ~40% of revenue. Capital stays light (sales-to-capital ~3.0). The €548M net cash and zero financial debt underwrite the option value of disciplined bolt-on M&A (Netstal 2024, Ampco 2023) and absorb the inevitable capex-cycle slowdowns. The market is reading event-driven Q1 EPS softness (−9.6%, mostly FX translation and the Ingeniq transition's flagged 100bp drag through 2027) as if it were structural damage. It isn't.
Two debates worth pressure-testing
- WACC corrected via β triangulation. Earlier pass used Damodaran's US Machinery subset (β_u 0.89, β_lev 0.92), giving WACC 7.70%. A correction to global Machinery (β_u 1.33, β_lev 1.37) gave WACC 10.30%, but the multi-source 5Y regression β for KRN is 0.95 (Yahoo, StockAnalysis, SimplyWallSt all agree). With KRN at near-zero D/E (€5M total debt vs €3.7B market cap), regression β ≈ unlevered β. The 44% gap between regression and Damodaran-global triggers our triangulation rule → trust regression. Final: β 0.95, Ke 8.12%, WACC 7.88%, MoS +41.8%.
- Margin target stays sub-sector. We hold 8% Y10 EBIT vs the Machinery industry standard ~16% — Krones is equipment-heavy, not pure-play service/software, so the industry median doesn't fit.
- Capital-light credit honored. Sales-to-capital 3.0, well above the Machinery 1.95 standard, but consistent with Krones' realized 2.5-3.3 bracket and ROCE-expansion trail.
- Governance haircut only 5%. The controlling Kronseder pool would normally earn 15-25%; we anchor at 5% on the 75-year track record + net-buying family vehicle. Skeptical readers can bump it to 15% and still see ~+22% MoS.
- FY26 guide-anchored, not FY25 peak. Sell-side consensus still drags toward the FY25 €417M EBIT peak; we anchor to the guided FY26 walk and the realized FY26 cc growth trajectory.
- PET → aluminum transition stalls. If consumer or regulatory pressure on aluminum eases, the line-conversion replacement-cycle thesis softens; growth drops to 2-3% over the explicit period.
- Emerging-market FX drag persists. ~30% of revenue is Mexico / India / MEA-exposed; sustained EM FX weakness compresses EUR translation (already visible in Q1 2026 −2.2% reported vs +1.4% cc).
- Beverage capex pauses 2027+. Backlog burns down, Y3-5 revenue disappoints. Mitigated by €548M net cash absorbing any single-cycle slowdown without forcing capital choices.
- Chinese competitor commoditization. Substack bear thesis: lower-end PET/can lines compress margin back to 6-7% by Y10; service annuity cannibalized by 3rd-party retrofits.
- Family-control governance optics. 2023 DAX-family removal over C.10 committee form is real; the 5% haircut prices the form gap, but a regulator-driven re-rating could widen it.
Risks to thesis
If consumer or regulatory pressure on aluminum eases, the line-conversion replacement-cycle thesis softens; growth drops to 2-3% explicit period.
~30% revenue from Mexico/India/MEA; sustained EM FX weakness compresses EUR translation (already visible in Q1 2026 -2.2% reported vs +1.4% cc).
If beverage capex pauses 2027+, backlog burns down and Y3-5 growth disappoints. Mitigated by €548M net cash absorbing any single-cycle slowdown.
Substack bear thesis: lower-end PET/can lines compress margin back to 6-7% by Y10; service annuity cannibalized by 3rd-party retrofits.
75-year pro-minority track record; 2023 DAX-family removal over C.10 committee form is governance optics, not value extraction. Priced via 0.05 haircut.
Top 10 customers ~40% revenue, spread across Coca-Cola / Pepsi / AB InBev / Heineken bottlers — diversified by geography and product line.
10-year forecast
Revenue + FCFF on the left axis; operating margin on the right axis.
Monte Carlo distribution
Even at the 5th-percentile outcome (€163.24), intrinsic value still exceeds today's €117.80 price by 38% — the disagreement isn't whether Krones is undervalued, but by how much.
Mean €201.27 ± €24.72 across 1000 iterations (0 failed) · P(intrinsic < market €117.80) = 0.0%.
- terminal_growth (0.0240) >= risk_free_rate (0.0240); the stable-growth ceiling is the risk-free rate
Cost of capital build
| Risk-free rate | ~2.40% | implied from CE − β·(ERP+CRP) |
| Mature-market ERP (assumed) | 4.23% | 2026 global mature-market ERP |
| Levered β | 0.9500 | 5Y regression (Yahoo/StockAnalysis/SimplyWallSt triangulated) |
| Weighted CRP | 1.79% | country mix × per-country |
| Cost of equity | 8.12% | |
| Pre-tax cost of debt | 1.96% | synth rating Aaa/AAA |
| WACC | 7.88% | |
| Terminal growth | 2.40% | |
| Terminal ROIC | 15.00% |
Full year-by-year DCF
| Year | Revenue | Op mgn | EBIT | EBIT(1−t) | Reinvest | FCFF | PV |
|---|---|---|---|---|---|---|---|
| 1 | €5.89B | 7.4% | €437M | €311M | €76M | €235M | €218M |
| 2 | €6.13B | 7.5% | €459M | €326M | €79M | €247M | €212M |
| 3 | €6.37B | 7.6% | €481M | €342M | €82M | €260M | €207M |
| 4 | €6.63B | 7.6% | €505M | €358M | €85M | €273M | €202M |
| 5 | €6.89B | 7.7% | €529M | €376M | €88M | €287M | €197M |
| 6 | €7.17B | 7.7% | €555M | €393M | €92M | €301M | €191M |
| 7 | €7.45B | 7.8% | €582M | €411M | €96M | €315M | €185M |
| 8 | €7.75B | 7.9% | €610M | €430M | €99M | €330M | €180M |
| 9 | €8.06B | 7.9% | €640M | €449M | €103M | €346M | €175M |
| 10 | €8.38B | 8.0% | €671M | €470M | €107M | €362M | €170M |
Methodology & flags
FCFF DCF, 10y explicit + perpetuity. R&D capitalisation: OFF · Lease capitalisation: OFF · Failure-rate adjustment: OFF · ESO subtraction: OFF.